Skip to main content
Top

Identification and longitudinal assessment of sepsis phenotypes derived from routine clinical data in critically ill patients: a retrospective repeated measures latent profile analysis

Abstract

Background

The definition of sepsis as an organ dysfunction with dysregulated host response leads to a considerable heterogeneity in this cohort of patients. Research is ongoing to identify subgroups of septic patients who share a common, potentially treatable pathomechanism. There are now several examples of reproducible subgroups, but they often rely on complex biomarker panels and data on their longitudinal stability are scarce, which limits their translation to the bedside. The objective of this study was to identify sepsis subgroups using routinely available clinical data and to assess the temporal stability of these subgroups.

Methods

We retrospectively collected data on all adult patients treated for sepsis according to sepsis-3 criteria in our intensive care unit at a university hospital in Germany between 2013 and 2021. Subgroup identification was performed using latent profile analysis, based on data collected within 48 h of the onset of their sepsis, and was repeated with data collected 120–144 h after onset. We assessed the stability of subgroup assignment over time and the in-hospital mortality of these subgroups.

Results

The analysis included 637 patients with sepsis, 83% of whom were in septic shock. Latent profile analysis of clinical data from the first period identified four subgroups with a high median probability of class membership in all subgroups and distinct characteristics. Subgroup 1 included 76 patients (12%) and was characterized by a hepatobiliary and cardiovascular dysfunction. Subgroup 2, which included 242 patients (38%), showed the least inflammation and organ dysfunction. Subgroup 3 included 236 patients (37%) and was characterized by hyperinflammation. Subgroup 4 included 83 patients (13%) who were older and had more comorbidities. They tended to have high procalcitonin and INR levels. In-hospital mortality was excessive in Subgroup 1 and lowest in Subgroups 4 and 2. In the longitudinal assessment conducted at 120–144 h post-inclusion, subgroup 1 demonstrated the greatest stability over time.

Conclusion

Analysis of clinical routine data identified four distinct clinical subgroups. In the longitudinal analysis, subgroup 1, which was characterized by hepatobiliary dysfunction and high mortality, demonstrated stability over the course of the illness.
Title
Identification and longitudinal assessment of sepsis phenotypes derived from routine clinical data in critically ill patients: a retrospective repeated measures latent profile analysis
Authors
Carolin Jung
Niklas Oetzmann
Hans-Joerg Gillmann
Thomas Stueber
Publication date
23-07-2025
Publisher
Springer Berlin Heidelberg
Published in
Infection
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-025-02607-8
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on progress in colorectal cancer

  • Live
  • Webinar | 11-12-2025 | 18:00 (CET)

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Watch it live: Thursday 11 December 2025, 18:00-19:30 (CET)

Prof. Antoni Castells
Prof. Edward Giovannucci
Developed by: Springer Medicine
Join the webinar
Webinar

2025 ESMO Congress hub

Unlock your free and exclusive access to expert interviews, news, and more from the annual congress of the European Society for Medical Oncology.

Read more

UEG Week 2025

Unlock your free and exclusive access to the latest news and expert interviews from UEG Week, United European Gastroenterology's annual congress.

Read more

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Developed by: Springer Medicine
Watch now
Video
Image Credits
Colon cancer illustration/© (M) KATERYNA KON/SCIENCE PHOTO LIBRARY / Getty Images, Cancer cell screening and treatment concept/© artacet / iStock / Getty Images Plus, 3D-rendered X-ray style illustration of the human gastrointestinal tract/© libre de droit / iStock / Getty Images Plus, Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images